Works by Takano, Masashi

Results: 106
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.

    Published in:
    Supportive Care in Cancer, 2014, v. 22, n. 11, p. 2891, doi. 10.1007/s00520-014-2280-6
    By:
    • Takeshima, Nobuhiro;
    • Matoda, Maki;
    • Abe, Masakazu;
    • Hirashima, Yasuyuki;
    • Kai, Kentaro;
    • Nasu, Kaei;
    • Takano, Masashi;
    • Furuya, Kenichi;
    • Sato, Seiya;
    • Itamochi, Hiroaki;
    • Tsubamoto, Hiroshi;
    • Hasegawa, Kosei;
    • Terao, Kiminari;
    • Otsuki, Takeo;
    • Kuritani, Keiko;
    • Ito, Kimihiko
    Publication type:
    Article
    14
    15

    Predicting time to ovarian carcinoma recurrence using protein markers.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3740, doi. 10.1172/JCI68509
    By:
    • Ji-Yeon Yang;
    • Kosuke Yoshihara;
    • Kenichi Tanaka;
    • Masayuki Hatae;
    • Hideaki Masuzaki;
    • Hiroaki Itamochi;
    • Masashi Takano;
    • Kimio Ushijima;
    • Tanyi, Janos L.;
    • Coukos, George;
    • Yiling Lu;
    • Mills, Gordon B.;
    • Verhaak, Roel G. W.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 335, doi. 10.1007/s00280-015-2793-9
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Okada, Satoshi;
    • Otsuki, Takeo;
    • Fujiwara, Kiyoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Hasumi, Yoko;
    • Takei, Yuji;
    • Hasegawa, Tetsuya;
    • Matsumoto, Takashi;
    • Fujiwara, Keiichi;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Shimada, Muneaki;
    • Suzuki, Mitsuaki;
    • Kigawa, Junzo
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
    By:
    • Fujiwara, Hiroyuki;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Takano, Masashi;
    • Yoshino, Kiyoshi;
    • Kawano, Yoshiaki;
    • Hirashima, Yasuyuki;
    • Nagase, Satoru;
    • Nishio, Shin;
    • Nishikawa, Tadaaki;
    • Ito, Kimihiko;
    • Shoji, Tadahiro;
    • Kimura, Eizo;
    • Takano, Tadao;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Fujiwara, Keiichi;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    43
    44
    45
    46
    47

    Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2007, v. 12, n. 4, p. 256, doi. 10.1007/s10147-007-0670-1
    By:
    • Takano, Masashi;
    • Sugiyama, Toru;
    • Yaegashi, Nobuo;
    • Suzuki, Mitsuaki;
    • Tsuda, Hiroshi;
    • Sagae, Satoru;
    • Udagawa, Yasuhiro;
    • Kuzuya, Kazuo;
    • Kigawa, Junzo;
    • Takeuchi, Satoshi;
    • Tsuda, Hitoshi;
    • Moriya, Takuya;
    • Kikuchi, Yoshihiro
    Publication type:
    Article
    48
    49
    50